Sarcopenia in Older Patients in the Acute Hospital Setting
The Identification and Prevention of Sarcopenia in Older Patients in the Acute Hospital Setting
Rambam Health Care Campus
50 participants
Apr 18, 2021
INTERVENTIONAL
Conditions
Summary
This study will assess whether the use of technology using the Virtual Gate Device (VGD) will prevent or minimize the development of hospital acquired Sarcopenia resulting from Immobilization.
Eligibility
Inclusion Criteria4
- Male and female patients 75 years of age and older.
- Patients admitted with an acute infection (clinically from a respiratory or urinary source).
- Expected length of hospitalization of at least 4 days.
- Patients who are conscious and cognitively able to provide written informed consent as determined by a score of 0 on the 4AT scale
Exclusion Criteria5
- Male and female patients under 75 years of age.
- Expected length of hospitalization of less than 4 days.
- A condition limiting the use of the virtual gate device (VGD) due to factors relating to discomfort or safety, including but not limited to: fracture, amputation, local infection, pain, paralysis of one or both lower limbs, cardiac arrhythmia or cardiac pacemaker.
- Patients who are unable to or do not provide informed consent for participation.
- A score 1 or more on the 4AT scale.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A VGD will be applied to one randomly-assigned lower limb. The VGD will be operated constantly (apart from times that the patient is being bathed or undergoing investigations or procedures) providing intermittent stimulations for a maximum of 10 days.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04092790